Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 1 open reading frame 198 (C1orf198) is a widely expressed serine- and proline-rich protein with highest expression in lung, brain, and spinal cord tissues. Encoded on chromosome 1q42, it contains a conserved domain of unknown function (DUF4706). Conditional expression depends on upstream regulatory proteins such as FBP2 and is predicted to be regulated by transcription factors including HIF (hypoxia-induced factor), USF, ETS, and XCPE1, linking it to cellular responses to oxygen deprivation. Subcellular localization is primarily cytoplasmic, with possible mitochondrial targeting. Notably, C1orf198 interacts with the mitochondrial import receptor TOMM20 and hypoxia-associated factor SART1, reinforcing its potential involvement in hypoxia and mitochondrial biology. There is currently no direct evidence implicating C1orf198 in therapeutic targeting, disease causality, or biomarker utility. Its molecular role remains to be fully elucidated
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 1 open reading frame 198 (C1orf198).